Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Colorectal Cancer

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Colorectal Cancer in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buffa, F; Fedele, V; Fischer, R; Harris, A; Huang, HL; Igarashi, K; Jones, D; Kessler, B; Mccarthy, M; Mccullagh, J; Moutsianas, L; Rodriguez, M; Sato, M; Soga, T; Valli, A; Van Stiphout, R; Vinaxia, M; Yanes, O1
Bouvier, S; Cubertafond, P; Denizot, Y; Gainant, A; Guglielmi, L; Mathonnet, M1
Denizot, Y; Descottes, B; Labrousse, F; Mathonnet, M; Truffinet, V; Valleix, D1
George, I; Itzkowitz, S; Lin, A; Mayer, L; Mehra, M; Ogata, S; Shim, J; Sperber, K1
Berdel, WE; Danhauser-Riedl, S; Houlihan, WJ; Koenigsmann, M; Reufi, B; Thiel, E; Zafferani, M1

Other Studies

5 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Colorectal Cancer

ArticleYear
Hypoxia induces a lipogenic cancer cell phenotype via HIF1α-dependent and -independent pathways.
    Oncotarget, 2015, Feb-10, Volume: 6, Issue:4

    Topics: Acetyl-CoA C-Acyltransferase; Acetyl-CoA Carboxylase; Aged; Basic Helix-Loop-Helix Transcription Factors; Blotting, Western; Cell Hypoxia; Cell Line, Tumor; Colorectal Neoplasms; Fatty Acids; Female; Genomics; HCT116 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lipid Metabolism; Lipids; Male; Metabolomics; Middle Aged; Platelet Activating Factor; Proteomics; RNA Interference; Signal Transduction

2015
Tissue concentrations of platelet-activating factor in colorectal carcinoma: inverse relationships with Dukes' stage of patients.
    Oncogene, 2003, Oct-16, Volume: 22, Issue:46

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Biomarkers, Tumor; Colonic Neoplasms; Colorectal Neoplasms; Humans; Neoplasm Staging; Phospholipases A; Platelet Activating Factor

2003
Platelet-activating factor and liver metastasis of colorectal cancer.
    International journal of cancer, 2005, Jan-20, Volume: 113, Issue:3

    Topics: Antigens, Human Platelet; Colon; Colorectal Neoplasms; Epitopes; Female; Humans; Inflammation Mediators; Liver Neoplasms; Male; Middle Aged; Phospholipases A; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Rectum; RNA, Messenger

2005
Mucin secretion in inflammatory bowel disease: comparison of a macrophage-derived mucin secretagogue (MMS-68) to conventional secretagogues.
    Inflammatory bowel diseases, 1998, Volume: 4, Issue:1

    Topics: Carbachol; Colitis, Ulcerative; Colorectal Neoplasms; Crohn Disease; Epithelial Cells; Glycoproteins; Humans; In Vitro Techniques; Intestinal Secretions; Leukotriene C4; Macrophages; Mucins; Platelet Activating Factor; Tumor Cells, Cultured

1998
Lack of therapeutic effects of platelet activating factor antagonists in WEHI-3B leukemia, human xenotransplanted colorectal and lung cancer and Lewis-lung tumor in vivo.
    Cancer letters, 1992, Dec-24, Volume: 67, Issue:2-3

    Topics: Animals; Antineoplastic Agents; Colorectal Neoplasms; Drug Screening Assays, Antitumor; Female; Humans; Imidazoles; Isoquinolines; Leukemia, Experimental; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Neoplasm Transplantation; Piperidines; Platelet Activating Factor

1992